Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

MLA

Na Jia, et al. “Influence of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on the Risk of All‐cause Mortality and Other Clinical Outcomes in Patients with Confirmed COVID‐19: A Systemic Review and Meta‐analysis.” The Journal of Clinical Hypertension, vol. 23, no. 9, Sept. 2021, pp. 1651–63. EBSCOhost, https://doi.org/10.1111/jch.14329.

APA

Na Jia, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, Sitong Dong, Jun Xia, Ping Zeng, & Deping Liu. (2021). Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis. The Journal of Clinical Hypertension, 23(9), 1651–1663. https://doi.org/10.1111/jch.14329

Chicago

Na Jia, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, Sitong Dong, Jun Xia, Ping Zeng, and Deping Liu. 2021. “Influence of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on the Risk of All‐cause Mortality and Other Clinical Outcomes in Patients with Confirmed COVID‐19: A Systemic Review and Meta‐analysis.” The Journal of Clinical Hypertension 23 (9): 1651–63. doi:10.1111/jch.14329.